drugset / Trial / NCT01248468
Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to compare the efficacy and safety of aspirin, acetaminophen and caffeine (AAC) with sumatriptan and placebo in the acute treatment of migraine.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 250 mg | — |
| Subject | Aspirin | Small molecule | 250 mg | — |
| Subject | Caffeine | Small molecule | 65 mg | — |
| Comparator | Sumatriptan | Unknown | 100 mg | — |